JP2015528466A5 - - Google Patents

Download PDF

Info

Publication number
JP2015528466A5
JP2015528466A5 JP2015530070A JP2015530070A JP2015528466A5 JP 2015528466 A5 JP2015528466 A5 JP 2015528466A5 JP 2015530070 A JP2015530070 A JP 2015530070A JP 2015530070 A JP2015530070 A JP 2015530070A JP 2015528466 A5 JP2015528466 A5 JP 2015528466A5
Authority
JP
Japan
Prior art keywords
urea
bar
inclusion body
high pressure
inclusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015530070A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015528466A (ja
JP6405308B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/057430 external-priority patent/WO2014036349A1/en
Publication of JP2015528466A publication Critical patent/JP2015528466A/ja
Publication of JP2015528466A5 publication Critical patent/JP2015528466A5/ja
Application granted granted Critical
Publication of JP6405308B2 publication Critical patent/JP6405308B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015530070A 2012-08-30 2013-08-30 キメラksacタンパク質の発現及び高圧により可溶性タンパク質を製造する方法 Expired - Fee Related JP6405308B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261694968P 2012-08-30 2012-08-30
US61/694,968 2012-08-30
US201361830425P 2013-06-03 2013-06-03
US61/830,425 2013-06-03
PCT/US2013/057430 WO2014036349A1 (en) 2012-08-30 2013-08-30 Expression of chimeric ksac protein and method of producing soluble proteins by high pressure

Publications (3)

Publication Number Publication Date
JP2015528466A JP2015528466A (ja) 2015-09-28
JP2015528466A5 true JP2015528466A5 (https=) 2016-08-12
JP6405308B2 JP6405308B2 (ja) 2018-10-17

Family

ID=49162270

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015530070A Expired - Fee Related JP6405308B2 (ja) 2012-08-30 2013-08-30 キメラksacタンパク質の発現及び高圧により可溶性タンパク質を製造する方法
JP2015530066A Active JP6438396B2 (ja) 2012-08-30 2013-08-30 不活化ワクチンを作製するための、ならびに組換えタンパク質をリフォールディング/可溶化させるための高圧デバイスおよび方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015530066A Active JP6438396B2 (ja) 2012-08-30 2013-08-30 不活化ワクチンを作製するための、ならびに組換えタンパク質をリフォールディング/可溶化させるための高圧デバイスおよび方法

Country Status (18)

Country Link
US (3) US9169302B2 (https=)
EP (2) EP2890392B1 (https=)
JP (2) JP6405308B2 (https=)
KR (1) KR102208844B1 (https=)
CN (3) CN104768577B (https=)
AP (1) AP2015008331A0 (https=)
AU (4) AU2013308627B2 (https=)
BR (1) BR112015004463B8 (https=)
CA (2) CA2883296A1 (https=)
EA (1) EA031988B1 (https=)
ES (1) ES2744709T3 (https=)
HK (1) HK1211874A1 (https=)
MD (1) MD4608C1 (https=)
MX (3) MX358782B (https=)
NZ (3) NZ706288A (https=)
PH (1) PH12015500700B1 (https=)
RU (1) RU2647568C2 (https=)
WO (2) WO2014036349A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8968749B2 (en) * 2006-07-21 2015-03-03 Universidade Federal De Minas Gerais—Ufmg Vaccine composition and immunization method
NZ706288A (en) 2012-08-30 2016-06-24 Merial Inc Expression of chimeric ksac protein and method of producing soluble proteins by high pressure
ZA201501696B (en) 2012-08-30 2016-01-27 Merial Ltd Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins
EP2978447B1 (en) * 2013-03-28 2019-05-08 Infectious Disease Research Institute Vaccines comprising leishmania polypeptides for the treatment and diagnosis of leishmaniasis
CN104758944B (zh) 2015-04-02 2017-11-28 中国科学院过程工程研究所 一种疫苗制剂及其制备方法和用途
JP2018082987A (ja) * 2016-11-25 2018-05-31 株式会社日立製作所 ウイルス不活化方法及びウイルス不活化装置
JP2020152644A (ja) * 2019-03-18 2020-09-24 国立大学法人愛媛大学 Vnarのリフォールディング方法およびvnarの製造方法
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
US12537071B1 (en) 2020-07-22 2026-01-27 David Gordon Bermudes Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins
CN112120012B (zh) * 2020-09-30 2022-03-22 广东康盾创新产业集团股份公司 一种car-t细胞冻存方法
BR102021000794A2 (pt) * 2021-01-15 2022-07-26 Fundação Oswaldo Cruz Proteína quimérica, kit, método para diagnóstico de leishmaniose, uso de uma proteína quimérica, composição vacinal contra leishmaniose visceral, e, uso de uma composição vacinal

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708871A (en) 1983-03-08 1987-11-24 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
JP2743177B2 (ja) * 1987-04-24 1998-04-22 財団法人阪大微生物病研究会 百日咳菌の培養方法、及び百日咳トキソイドとその混合ワクチン
ES2241042T3 (es) 1996-10-11 2005-10-16 The Regents Of The University Of California Conjugados de polinucleotido inmunoestimulador/ molecula inmunomoduladora.
US5980912A (en) 1997-03-25 1999-11-09 Zonagen, Inc. Chitosan induced immunopotentiation
FR2771011B1 (fr) 1997-11-17 2000-01-28 Hippocampe Obtention de vaccins destines a prevenir les effets pathogenes associes a une infection retrovirale
FR2775601B1 (fr) 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves
FR2776928B1 (fr) 1998-04-03 2000-06-23 Merial Sas Vaccins adn adjuves
AU4975699A (en) 1998-07-09 2000-02-01 University Technology Corporation High pressure refolding of protein aggregates and inclusion bodies
EP1180945A1 (en) 1999-05-28 2002-02-27 Universite Laval Inactivation of food spoilage and pathogenic microorganisms by dynamic high pressure
US6645740B1 (en) 1999-06-10 2003-11-11 Merial Limited Nucleic acids encodings equine GM-CSF
SK287400B6 (sk) 1999-09-25 2010-08-09 University Of Iowa Research Foundation Prostriedok s obsahom imunostimulačnej nukleovej kyseliny a jeho použitie na stimuláciu imunitnej reakcie
US7615617B2 (en) 1999-10-25 2009-11-10 University Of Delaware Use of hydrostatic pressure to inhibit and reverse protein aggregation and facilitate protein refolding
WO2002056824A2 (en) 2000-08-10 2002-07-25 Boston Biomedica, Inc. Pressure cycling inactivation of pathogens in biological materials used for therapeutics or vaccines
US6635223B2 (en) * 2000-10-25 2003-10-21 Andreas Maerz Method for inactivating micro-organisms using high pressure processing
WO2002062827A2 (en) * 2000-10-31 2002-08-15 The Regents Of The University Of Colorado, A Body Corporate Improved protein disaggregation and refolding using high pressure
WO2004024027A2 (en) 2002-06-07 2004-03-25 University Of Florida Endodontic files made using bulk metallic glasses
SE525457C2 (sv) * 2002-06-24 2005-02-22 Flow Holdings Sagl Förfarande för åstadkommande av en tryckändring mellan två trycktillstånd, högtryckspressanordning samt användning av förfarande eller högtryckspressanordning
CN101052413B (zh) * 2003-11-05 2014-05-14 C.B.F.莱蒂私人有限公司 特异性组蛋白在治疗寄生虫病中的应用
US7993580B2 (en) 2004-08-24 2011-08-09 Baxter International Inc. Methods for the inactivation of microorganisms in biological fluids, flow through reactors and methods of controlling the light sum dose to effectively inactivate microorganisms in batch reactors
JP2009519706A (ja) 2005-11-21 2009-05-21 バロフォールド, インコーポレイテッド タンパク質の高圧リフォールディングのためのデバイスおよび方法
CN200945252Y (zh) * 2006-09-01 2007-09-12 天津市华泰森淼生物工程技术有限公司 手动开启式小型超高压生物处理设备
WO2008033556A2 (en) 2006-09-15 2008-03-20 Barofold, Inc. High pressure treatment of proteins for reduced immunogenicity
WO2008124139A1 (en) * 2007-04-05 2008-10-16 Barofold, Inc. High pressure inclusion body solubilization in the presence of a protease
US20080249286A1 (en) 2007-04-05 2008-10-09 Seefeldt Matthew B High-pressure refolding of proteins in the presence of binding partners
US8273561B2 (en) 2007-10-05 2012-09-25 Nuron Biotech, Inc. High pressure treatment of aggregated interferons
ES2763395T3 (es) * 2007-12-21 2020-05-28 Zoetis Services Llc Bacterinas tratadas térmicamente y vacunas de emulsión preparadas a partir de tales bacterinas tratadas térmicamente
BRPI0800357A2 (pt) 2008-03-10 2009-10-27 Fundacao Oswaldo Cruz método para produção de uma vacina estabilizada
MX348137B (es) 2008-05-08 2017-05-29 Merial Ltd Vacuna de la leishmaniasis con el uso del inmunogeno salival de la mosca de la arena.
US8425919B2 (en) 2008-05-21 2013-04-23 Infectious Disease Research Institute Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis
US8410258B2 (en) * 2008-05-21 2013-04-02 Infections Disease Research Institute Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis
US20100112660A1 (en) 2008-05-30 2010-05-06 Barofold, Inc. Method for Derivatization of Proteins Using Hydrostatic Pressure
US20110070219A1 (en) 2009-04-27 2011-03-24 Seefeldt Matthew B High pressure protein crystallization
WO2011091860A1 (en) * 2010-02-01 2011-08-04 Avure Technologies Ab High-pressure arrangement with locking element preventing rotation of load basket
CN201781934U (zh) * 2010-04-14 2011-04-06 中国农业大学 一种小型框架自动式超高压设备
WO2012012388A2 (en) 2010-07-19 2012-01-26 Barofold, Inc. Therapeutic protein compositions having reduced immunogenicity and/or improved efficacy
NZ706288A (en) * 2012-08-30 2016-06-24 Merial Inc Expression of chimeric ksac protein and method of producing soluble proteins by high pressure
ZA201501696B (en) * 2012-08-30 2016-01-27 Merial Ltd Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins

Similar Documents

Publication Publication Date Title
JP2015528466A5 (https=)
NZ745940A (en) Methods for providing single-stranded rna
MX2021012669A (es) Proceso para sintetizar 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5- il)-piridin-3-il)metoxi)benzaldehido.
WO2019126634A3 (en) Targeted integration of nucleic acids
MX2019010084A (es) Proceso para elaborar sal de metal alcalino de metilglicindiacetato (mgda) solido y particulas solidas.
PH12015502441B1 (en) Anti-il-4/anti-il-13 bispecific antibody formulations
NZ704092A (en) Ph adjusted pulse protein product
MY190283A (en) Method for producing crystals of diazabicyclooctane derivative and stable lyophilized preparation
MY156760A (en) Process for manufacturing succinic acid
NZ706288A (en) Expression of chimeric ksac protein and method of producing soluble proteins by high pressure
WO2014162308A3 (en) A method of preparing pure precious metal nanoparticles with large fraction of (100) facets, nanoparticles obtained by this method and their use
EP2862627A3 (en) Activated EU-2 zeolite and use thereof in hydroisomerization processes
WO2017025897A3 (en) Capped and uncapped antibody cysteines, and their use in antibody-drug conjugation
MX2019000031A (es) Procedimientos para la preparación de una solución de levotiroxina.
WO2017103600A8 (en) Preparation of respirable zafirlukast particles
MX2025002821A (es) Sistemas y metodos para reducir la formacion de impurezas durante la deshidrocloracion de 244bb a 1234yf
RU2012140308A (ru) Стабильный водный раствор акриламида
BRPI0816724A2 (pt) Processo para aumento do valor de ph de corpos de água ácidos
Hsu et al. Surface modification of commercially pure Ti treated with aqueous NaOH treatment and ethyl alcohol aging
NZ755989A (en) A method of inhibiting isomerization of a reducing saccharide upon thermal treatment
MY194572A (en) Self-sufficient process for the production of biomass hydrolysate with reduced salt content
MX2015017641A (es) Proceso para la regeneracion de un catalizador de metal noble soportado.
MX2022005430A (es) Metodo de almacenamiento de un biocatalizador.
JP2018033559A5 (https=)
IN2014MU00328A (https=)